JudyORourkeThe blizzard of tweets flew fast, whiffling re-tweets midair during the recent Personalized Medicine World Conference held in the Silicon Valley.

Heavy crates of information were distilled into quick quips about how we can and should explode personalized medicine’s potential. About how reimbursement is spurring change in how medical care is dispensed, genome management versus simply genetic testing, Lee Hood’s P-4 medicine paradigm and the role of data, single-cell analysis, enmeshing genomics with EMRs…

In the mix for realizing this potential is orchestrating the side-by-side evolution of life science technology and information technology, and integrating their data’s DNA.

Advances in testing, including next-generation sequencing, and in IT, are playing an increasing role today in delivering advances in genomic analysis to patients who have cancer.

Personalized cancer treatment helps physicians and their patients to battle cancer at the genomic level by finding and targeting molecular changes discovered within cancer cells. In this issue we go behind the scenes and into the lab at Foundation Medicine, to learn how its experts are aiming to transform the management of cancer patients.

On another note, even though the transition to ICD-10 codes won’t go into effect until October 2014, we know you’re working now to gear up.

To guarantee that vendors and payors are set to process ICD-10 claims by the compliance date, labs need to contact their billing and laboratory information system vendors to find out if software or hardware updates are needed, learn when updates will be installed, establish timelines, and familiarize themselves with the vendor’s overall plan for upgrading the systems to support ICD-10.

Will the software update support ICD-9 and ICD-10 to accommodate transactions for services provided before the transition date that are submitted after October 1, 2014? You will need a crosswalk between these code sets that permits you to search in ICD-9 and find the related ICD-10 code(s). Allow sufficient time to train test all systems involved in the process.

You may have noticed that CLP recently adopted the digital-first publishing model, which means we’re now publishing articles online in advance of print. Please visit our website often (www.clpmag.com), as I’m updating the content frequently.

We’re putting the finishing touches on a special web-exclusive feature article titled “High-Sensitivity Troponin: Quality and Productivity in Near Patient Testing,” written by David Stein, PhD, Connie Mardis, MEd, and Amy Sarli—check back with CLP next week, when I’ll be publishing this piece online.

Thank you for engaging with CLP!

Judy O’Rourke   
Editor, CLP
[email protected], (619) 659-1065 — Follow me on Twitter (@editorCLPmag)